A promising new therapy, the FDA approval of Lipfendra, and updated cholesterol guidelines are expanding treatment options ...
Morning Overview on MSN
A new cholesterol drug just became the first of its kind you can swallow instead of inject
Millions of Americans who need aggressive cholesterol lowering but dread regular injections now have a new option: a ...
The Food and Drug Administration has approved a new kind of drug to cut cholesterol. So we've called up NPR health correspondent Rob Stein to learn what it can do. Good morning, Rob. ROB STEIN, BYLINE ...
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
Everyday Health on MSN
The FDA just approved a new medication to treat high cholesterol
Lipfendra (enlicitide) is the first PCSK9 inhibitor in a pill, and can help get LDL ‘bad’ cholesterol in check when statins aren’t cutting it.
The FDA has approved the first once-daily oral PCSK9 inhibitor, to lower LDL cholesterol in adults with high cholesterol and certain inherited cholesterol disorders. Experts explain who may benefit.
High cholesterol is one of the major risk factors for heart disease and stroke. While statins have been the most common treatment for high cholesterol for seve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results